The biopharmaceutical tubing market is expected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028.
The factors increasing elderly population in world, and rising demand for minimally invasive procedures are contributing to the market growth. However, the stringent regulatory frameworks hinder the biopharmaceutical tubing market growth.
Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.
Increase in life expectancy is leading to rise in geriatric population in the world. According to the World Health Organization (WHO), the global population share of people with age >60 would nearly double from 12% in 2015 to 22% in 2050. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people with age 60 or above in the world, and the number is expected to reach ~2.1 billion by 2050. In addition, according to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, their population share would grow from ~15% to ~24% during this period. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the highest percentage of people over the age of 60 that is (25%). Other regions of the world are also experiencing accelerated ageing, and by 2050, all regions of the world except Africa will have approximately a quarter or more of their populations aged 60 and over. The geriatric population in the world is anticipated to reach US$ 1.4 billion, US$ 2.1 billion, and above US$ 3.1 billion by 2030, 2050, and 2100, respectively.
This rise in the elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also resulting in the spike in incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the increase in chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.
Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal, and silicone. In 2020, the silicone segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021-2028. The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing. In addition to biocompatibility, high temperature and chemical resistance, mechanical strength, and electric properties are among the properties that make it a material of choice in biological applications.
Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment is sub segmented as single use technology, and others. The pharmaceutical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Liquid transfer is an essential part of pharmaceutical manufacturing processes, including the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) such as vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment. Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industries demand ultra-pure and corrosion-resistant systems for liquid transfer that withstand harsh environment of chemicals, which is bolstering the market growth of this segment.
A few major primary and secondary sources referred to while preparing the report on the global biopharmaceutical tubing market are the United States Pharmacopeia (USP), Watson-Marlow Fluid Technology Group (WMFTG), The Italian Institute of Statistics (ISTAT), Asthma and Immunology Society, United Nation’s World Population Ageing 2017 report, and US Census Bureau.
Reasons to Buy
The factors increasing elderly population in world, and rising demand for minimally invasive procedures are contributing to the market growth. However, the stringent regulatory frameworks hinder the biopharmaceutical tubing market growth.
Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.
Increase in life expectancy is leading to rise in geriatric population in the world. According to the World Health Organization (WHO), the global population share of people with age >60 would nearly double from 12% in 2015 to 22% in 2050. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people with age 60 or above in the world, and the number is expected to reach ~2.1 billion by 2050. In addition, according to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, their population share would grow from ~15% to ~24% during this period. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the highest percentage of people over the age of 60 that is (25%). Other regions of the world are also experiencing accelerated ageing, and by 2050, all regions of the world except Africa will have approximately a quarter or more of their populations aged 60 and over. The geriatric population in the world is anticipated to reach US$ 1.4 billion, US$ 2.1 billion, and above US$ 3.1 billion by 2030, 2050, and 2100, respectively.
This rise in the elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also resulting in the spike in incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the increase in chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.
Type Insights
Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal, and silicone. In 2020, the silicone segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021-2028. The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing. In addition to biocompatibility, high temperature and chemical resistance, mechanical strength, and electric properties are among the properties that make it a material of choice in biological applications.
Application Insights
Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment is sub segmented as single use technology, and others. The pharmaceutical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Liquid transfer is an essential part of pharmaceutical manufacturing processes, including the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) such as vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment. Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industries demand ultra-pure and corrosion-resistant systems for liquid transfer that withstand harsh environment of chemicals, which is bolstering the market growth of this segment.
A few major primary and secondary sources referred to while preparing the report on the global biopharmaceutical tubing market are the United States Pharmacopeia (USP), Watson-Marlow Fluid Technology Group (WMFTG), The Italian Institute of Statistics (ISTAT), Asthma and Immunology Society, United Nation’s World Population Ageing 2017 report, and US Census Bureau.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biopharmaceutical tubing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Biopharmaceutical Tubing Market - By Type
1.3.2 Global Biopharmaceutical Tubing Market - By Application
1.3.3 Global Biopharmaceutical Tubing market - By Geography
2. Biopharmaceutical Tubing Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Biopharmaceutical Tubing Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.3 Middle East and Africa (MEA) - PEST Analysis
4.3.1 South and Central America (SCAM) - PEST Analysis
4.4 Expert Opinions
5. Investment in Biopharmaceutical Tubing
5.1 Introduction
5.2 Investment Made by Companies
6. Price of Overall Silicone Feedstock in Regions - Biopharmaceutical Tubing Market
6.1 North America
6.2 Europe
6.3 Asia Pacific
7. Adoption of Alternative Materials
8. Supply Shortages Faced by the Market Participants - Biopharmaceutical Tubing Market
8.1 Causes
9. Price Fluctuation
10. Total Production Capacity of Major Player -Biopharmaceutical Tubing Market
11. Biopharmaceutical Tubing Market - Key Market Dynamics
11.1 Drivers
11.1.1 Increasing Elderly Population in World
11.1.2 Rising Demand for Minimally Invasive Procedures
11.2 Market Restraints
11.2.1 Stringent Regulatory Framework
11.3 Market Opportunities
11.3.1 Proliferation of Healthcare Sector and Rise in Prevalence of Chronic Diseases in Developing Countries
11.4 Future Trends
11.4.1 Use of Platinum-Cured Silicone as Material of Choice for Biopharmaceutical Tubing
11.5 Impact Analysis
12. Biopharmaceutical Tubing Market - Global Analysis
12.1 Global Biopharmaceutical Tubing Market Revenue Forecast And Analysis
12.2 Global Biopharmaceutical Tubing Market, By Geography - Forecast And Analysis
12.3 Market Positioning of Key Players
13. Biopharmaceutical Tubing Market - Volume Analysis
13.1.1 Global: Biopharmaceutical Tubing Market, by Volume, 2019-2028 (Million Units)
14. Biopharmaceutical Tubing Market Analysis - By Type
14.1 Overview
14.2 Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
14.3 Plastic
14.3.1 Overview
14.3.2 Plastic: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
14.4 Metal
14.4.1 Overview
14.4.2 Metal: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
14.5 Silicone
14.5.1 Overview
14.5.2 Silicone: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
15. Biopharmaceutical Tubing Market Analysis - By Application
15.1 Overview
15.2 Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
15.3 Pharmaceutical
15.3.1 Overview
15.3.2 Pharmaceutical: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
15.4 Medical Devices
15.4.1 Overview
15.4.2 Medical Devices: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
15.5 Research and Development
15.5.1 Overview
15.5.2 Research and Development: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
15.6 Others
15.6.1 Overview
15.6.2 Others: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
16. Biopharmaceutical Tubing Market - Geographic Analysis
16.1 North America: Biopharmaceutical Tubing Market
16.1.1 Overview
16.1.2 North America: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.3 North America: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.1.4 North America: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.1.4.1 North America: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.1.5 North America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.1.5.1 US: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.5.1.1 US: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.5.1.2 US: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.1.5.1.3 US: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.1.5.1.3.1 US: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.1.5.2 Canada: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.5.2.1 Canada: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.5.2.2 Canada: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.1.5.2.3 Canada: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.1.5.2.3.1 Canada: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.1.5.3 Mexico: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.5.3.1 Mexico: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.1.5.3.2 Mexico Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.1.5.3.3 Mexico Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.1.5.3.3.1 Mexico Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.2 Europe: Biopharmaceutical Tubing Market
16.2.1 Overview
16.2.2 Europe: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.3 Europe: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.4 Europe: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.4.1 Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.2.5 Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028(%)
16.2.5.1 Germany: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.1.1 Germany: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.1.2 Germany: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.5.1.3 Germany: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.5.1.3.1 Germany: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.2.5.2 France: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.2.1 France: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.2.2 France: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.5.2.3 France: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.5.2.3.1 France: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.2.5.3 UK: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.3.1 UK: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.3.2 UK: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.5.3.3 UK: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.5.3.3.1 UK: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.2.5.4 Italy: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.4.1 Italy: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.4.2 Italy: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.5.4.3 Italy: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.5.4.3.1 Italy: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.2.5.5 Spain: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.5.1 Spain: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.5.2 Spain: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.5.5.3 Spain: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.5.5.3.1 Spain: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.2.5.6 Rest of Europe: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.6.1 Rest of Europe: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.2.5.6.2 Rest of Europe: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.2.5.6.3 Rest of Europe: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.2.5.6.3.1 Rest of Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3 Asia Pacific: Biopharmaceutical Tubing Market
16.3.1 Overview
16.3.2 Asia Pacific: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.3 Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.4 Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.4.1 Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3.5 Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.3.5.1 Japan: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.1.1 Japan: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.1.2 Japan: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.5.1.3 Japan: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.5.1.3.1 Japan: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3.5.2 China: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.2.1 China: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.2.2 China: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.5.2.3 China: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.5.2.3.1 China: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3.5.3 India: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.3.1 India: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.3.2 India: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.5.3.3 India: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.5.3.3.1 India: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3.5.4 South Korea: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.4.1 South Korea: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.4.2 South Korea: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.5.4.3 South Korea: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.5.4.3.1 South Korea: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3.5.5 Australia: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.5.1 Australia: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.5.2 Australia: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.5.5.3 Australia: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.5.5.3.1 Australia: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.3.5.6 Rest of Asia Pacific: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.6.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.3.5.6.2 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type, 2019-2028 (USD Million)
16.3.5.6.3 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application, 2019-2028 (USD Million)
16.3.5.6.3.1 Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals, 2019-2028 (USD Million)
16.4 Middle East & Africa: Biopharmaceutical Tubing Market
16.4.1 Overview
16.4.2 Middle East & Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
16.4.3 Middle East & Africa Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.4.4 Middle East & Africa Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.4.4.1 Middle East & Africa Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.4.5 Middle East & Africa: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.4.5.1 Saudi Arabia: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.1.1 Saudi Arabia: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.1.2 Saudi Arabia Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.4.5.1.3 Saudi Arabia Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.4.5.1.3.1 Saudi Arabia Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.4.5.2 UAE: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.2.1 UAE: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.2.2 UAE Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.4.5.2.3 UAE Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.4.5.2.3.1 UAE Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.4.5.3 South Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.3.1 South Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.3.2 South Africa Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.4.5.3.3 South Africa Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.4.5.3.3.1 South Africa Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.4.5.4 Rest of Middle East and Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.4.1 Rest of Middle East and Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.4.5.4.2 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.4.5.4.3 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.4.5.4.3.1 Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.5 South and Central America: Biopharmaceutical Tubing Market
16.5.1 Overview
16.5.2 South and Central America: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.3 South and Central America Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.5.4 South and Central America Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.5.4.1 South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.5.5 South and Central America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
16.5.5.1 Brazil: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.5.1.1 Brazil: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.5.1.2 Brazil Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.5.5.1.3 Brazil Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.5.5.1.3.1 Brazil Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.5.5.2 Argentina: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.5.2.1 Argentina: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.5.2.2 Argentina Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.5.5.2.3 Argentina Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.5.5.2.3.1 Argentina Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
16.5.5.3 Rest of South and Central America: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.5.3.1 Rest of South and Central America: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
16.5.5.3.2 Rest of South and Central America Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
16.5.5.3.3 Rest of South and Central America Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
16.5.5.3.3.1 Rest of South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
17. Impact of COVID-19 Pandemic on Global Biopharmaceutical Tubing Market
17.1 Global Impact of COVID-19
17.2 North America: Impact Assessment of COVID-19 Pandemic
17.3 Europe: Impact Assessment of COVID-19 Pandemic
17.4 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
17.5 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
17.6 South and Central America: Impact Assessment of COVID-19 Pandemic
18. Biopharmaceutical Tubing Market - Industry Landscape
18.1 Overview
18.2 Growth Strategies Done by the Companies in the Market, (%)
18.3 Organic Developments
18.3.1 Overview
18.4 Inorganic Developments
18.4.1 Overview
19. Company Profiles
19.1 W. L. Gore and Associates, Inc.
19.1.1 Key Facts
19.1.2 Business Description
19.1.3 Products and Services
19.1.4 Financial Overview
19.1.5 SWOT Analysis
19.1.6 Key Developments
19.2 Saint-Gobain Sekurit
19.2.1 Key Facts
19.2.2 Business Description
19.2.3 Products and Services
19.2.4 Financial Overview
19.2.5 SWOT Analysis
19.2.6 Key Developments
19.3 Freudenberg Group
19.3.1 Key Facts
19.3.2 Business Description
19.3.3 Products and Services
19.3.4 Financial Overview
19.3.5 SWOT Analysis
19.3.6 Key Developments
19.4 RAUMEDIC AG
19.4.1 Key Facts
19.4.2 Business Description
19.4.3 Products and Services
19.4.4 Financial Overview
19.4.5 SWOT Analysis
19.4.6 Key Developments
19.5 TEKNI-PLEX
19.5.1 Key Facts
19.5.2 Business Description
19.5.3 Products and Services
19.5.4 Financial Overview
19.5.5 SWOT Analysis
19.5.6 Key Developments
19.6 NewAge Industries, Inc.
19.6.1 Key Facts
19.6.2 Business Description
19.6.3 Products and Services
19.6.4 Financial Overview
19.6.5 SWOT Analysis
19.6.6 Key Developments
19.7 Optinova
19.7.1 Key Facts
19.7.2 Business Description
19.7.3 Products and Services
19.7.4 Financial Overview
19.7.5 SWOT Analysis
19.7.6 Key Developments
19.8 Zeus Industrial Products, Inc.
19.8.1 Key Facts
19.8.2 Business Description
19.8.3 Products and Services
19.8.4 Financial Overview
19.8.5 SWOT Analysis
19.8.6 Key Developments
19.9 NORDSON CORPORATION
19.9.1 Key Facts
19.9.2 Business Description
19.9.3 Products and Services
19.9.4 Financial Overview
19.9.5 SWOT Analysis
19.9.6 Key Developments
19.10 DuPont de Nemours, Inc.
19.10.1 Key Facts
19.10.2 Business Description
19.10.3 Products and Services
19.10.4 Financial Overview
19.10.5 SWOT Analysis
19.10.6 Key Developments
20. Company Profiles - For Supplier
20.1 Specialty Silicone Products, Inc.
20.1.1 Key Facts
20.1.2 Business Description
20.1.3 Products and Services
20.1.4 Financial Overview
20.2 Hoshine Silicon Industry Co., Ltd.
20.2.1 Key Facts
20.2.2 Business Description
20.2.3 Products and Services
20.2.4 Financial Overview
20.3 Wacker Chemie AG
20.3.1 Key Facts
20.3.2 Business Description
20.3.3 Products and Services
20.3.4 Financial Overview
20.4 Shin-Etsu Chemical Co., Ltd.
20.4.1 Key Facts
20.4.2 Business Description
20.4.3 Products and Services
20.4.4 Financial Overview
20.5 Momentive
20.5.1 Key Facts
20.5.2 Business Description
20.5.3 Products and Services
20.5.4 Financial Overview
20.6 Elkem ASA
20.6.1 Key Facts
20.6.2 Business Description
20.6.3 Products and Services
20.6.4 Financial Overview
20.7 Avantor, Inc.
20.7.1 Key Facts
20.7.2 Business Description
20.7.3 Products and Services
20.7.4 Financial Overview
21. Appendix
21.1 About The Publisher
21.2 Glossary of TermsList of Tables
Table 1. Adoption of Alternative Materials
Table 2. Global Biopharmaceutical Tubing Market, by Volume - Volume and Forecast to 2028 (Million Units)
Table 3. North America Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 4. North America Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 5. North America Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 6. US Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 7. US Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 8. US Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 9. Canada Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 10. Canada Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 11. Canada Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 15. Europe: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 16. Europe: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 17. Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 18. Germany: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 19. Germany: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 20. Germany: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 21. France: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 22. France: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 23. France: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 24. UK: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 25. UK: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 26. UK: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 27. Italy: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 28. Italy: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 29. Italy: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 30. Spain: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 31. Spain: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 32. Spain: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 33. Rest of Europe: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 34. Rest of Europe: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 35. Rest of Europe: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 36. Asia Pacific: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 37. Asia Pacific: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 38. Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 39. Japan: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 40. Japan: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 41. Japan: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 42. China: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 43. China: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 44. China: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 45. India: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 46. India: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 47. India: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 48. South Korea: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 49. South Korea: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 50. South Korea: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 51. Australia: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 52. Australia: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 53. Australia: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 54. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 55. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 56. Rest of Asia Pacific: Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 57. Middle East & Africa Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 58. Middle East & Africa Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 59. Middle East & Africa Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 60. Saudi Arabia Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 61. Saudi Arabia Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 62. Saudi Arabia Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 63. UAE Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 64. UAE Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 65. UAE Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 66. South Africa Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 67. South Africa Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 68. South Africa Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 69. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 70. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 71. Rest of Middle East and Africa Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 72. South and Central America Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 73. South and Central America Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 74. South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 75. Brazil Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 76. Brazil Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 77. Brazil Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 78. Argentina Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 79. Argentina Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 80. Argentina Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 81. Rest of South and Central America Biopharmaceutical Tubing Market, by Type - Revenue and Forecast to 2028 (USD Million)
Table 82. Rest of South and Central America Biopharmaceutical Tubing Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 83. Rest of South and Central America Biopharmaceutical Tubing Market, by Pharmaceuticals - Revenue and Forecast to 2028 (USD Million)
Table 84. Organic Developments Done By Companies
Table 85. Inorganic Developments Done By Companies
Table 86. Glossary of Terms, Biopharmaceutical Tubing Market
List of Figures
Figure 1. Biopharmaceutical Tubing Market Segmentation
Figure 2. Biopharmaceutical Tubing Market Segmentation, By Region
Figure 3. Biopharmaceutical Tubing Market Overview
Figure 4. Silicone Segment Held Largest Share of Biopharmaceutical Tubing Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Biopharmaceutical Tubing Market, by Geography (US$ Million)
Figure 7. Global Biopharmaceutical Tubing Market - Leading Country Markets (US$ Million)
Figure 8. Global Biopharmaceutical Tubing Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Price Fluctuation By Region
Figure 15. Total Production Capacity of Major Players
Figure 16. Global Biopharmaceutical Tubing Market - Revenue Forecast And Analysis - 2020- 2028
Figure 17. Global Biopharmaceutical Tubing Market - By Geography Forecast and Analysis - 2020- 2028
Figure 18. Market Positioning of Key Players In Global Biopharmaceutical Tubing Market
Figure 19. Biopharmaceutical Tubing Market Revenue Share, by Type (2021 and 2028)
Figure 20. Plastic: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 21. Metal: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 22. Silicone: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 23. Biopharmaceutical Tubing Market Revenue Share, by Application (2021 and 2028)
Figure 24. Pharmaceutical: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 25. Medical Devices: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Development: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (US$ Million)
Figure 28. North America: Biopharmaceutical Tubing Market, by Key Country - Revenue (2021) (USD Million)
Figure 29. North America Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 30. North America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 31. US: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 34. Europe: Biopharmaceutical Tubing Market, by Key Country - Revenue (2021) (USD Million)
Figure 35. Europe: Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 36. Europe: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 37. Germany: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 38. France: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 39. UK: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 40. Italy: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 41. Spain: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 42. Rest of Europe: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Asia Pacific: Biopharmaceutical Tubing Market, by Key Country - Revenue (2021) (USD Million)
Figure 44. Asia Pacific: Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 45. Asia Pacific: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 46. Japan: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 47. China: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 48. India: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 49. South Korea: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 50. Australia: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 51. Rest of Asia Pacific: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 52. Middle East & Africa: Biopharmaceutical Tubing Market, by Key Country - Revenue (2021) (USD Million)
Figure 53. Middle East & Africa Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 54. Middle East & Africa: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 55. Saudi Arabia: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 56. UAE: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 57. South Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 58. Rest of Middle East and Africa: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 59. South and Central America: Biopharmaceutical Tubing Market, by Key Country - Revenue (2021) (USD Million)
Figure 60. South and Central America Biopharmaceutical Tubing Market Revenue and Forecast to 2028 (USD Million)
Figure 61. South and Central America: Biopharmaceutical Tubing Market, by Country, 2021 & 2028 (%)
Figure 62. Brazil: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 63. Argentina: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 64. Rest of South and Central America: Biopharmaceutical Tubing Market - Revenue and Forecast to 2028 (USD Million)
Figure 65. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in North American Countries
Figure 66. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in European Countries
Figure 67. Impact of COVID-19 Pandemic in Asia-Pacific Country Markets
Figure 68. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in Middle East and Africa
Figure 69. Impact of COVID-19 Pandemic on Biopharmaceutical Tubing Market in South and Central America
Figure 70. Growth Strategies Done by the Companies in the Market, (%)
Companies Mentioned
- W. L. Gore and Associates, Inc.
- Saint-Gobain Sekurit
- Freudenberg Group
- RAUMEDIC AG
- TEKNI-PLEX
- NewAge Industries, Inc.
- Optinova
- Zeus Industrial Products, Inc.
- NORDSON CORPORATION
- DuPont de Nemours, Inc.
- Specialty Silicone Products, Inc.
- Hoshine Silicon Industry Co., Ltd.
- Wacker Chemie AG
- Shin-Etsu Chemical Co., Ltd.
- Momentive
- Elkem ASA
- Wacker Chemie AG
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 174 |
| Published | February 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 3442.82 million |
| Forecasted Market Value ( USD | $ 6013.27 million |
| Compound Annual Growth Rate | 8.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 17 |
